Literature DB >> 14636323

An Xp; Yq translocation causing a novel contiguous gene syndrome in brothers with generalized epilepsy, ichthyosis, and attention deficits.

Michael J Doherty1, Ian A Glass, Craig L Bennett, Phil D Cotter, Nate F Watson, Anna L Mitchell, Tom D Bird, Don F Farrell.   

Abstract

PURPOSE: We describe two brothers with generalized epilepsy, attention deficits, congenital ichthyosis, and Leri-Weill dyschondrosteosis who harbor an unusual Xp; Yq translocation chromosome, resulting in a novel contiguous gene syndrome because of deletion of genes from the distal short arm of the X chromosome.
METHODS: Physical examination, neuropsychologic testing, EEG, and neuroimaging studies were performed. Because of their unusual phenotype, karyotyping, fluorescence in situ hybridization, and further molecular analyses were carried out to refine the break points of the underlying unbalanced sex chromosome rearrangement.
RESULTS: The subjects had generalized epilepsy, X-linked ichthyosis, Madelung deformities, mesomelia, normal intelligence, and attention deficits. The brothers' karyotype was unbalanced; they inherited a maternal derivative X chromosome. Deleted distal Xp genes included short-stature homeobox on the X chromosome (SHOX), aryl sulfatase E (ARSE), variably charged X-chromosome mRNA gene A (VCX-A), and steroid sulfatase (STS). The final karyotype was 46,Y,der(X)t(X; Y)(p22.3; q11.2).ish der(X) (DXZ1+, KAL+, STS-, SHOX-) mat.
CONCLUSIONS: Loss of distal contiguous Xp genes resulted in a syndrome comprising bony deformities, ichthyosis, attention problems, and generalized epilepsy. Candidate epilepsy genes within the deleted segment, such as ASMT, a gene involved in the final synthesis of melatonin, are discussed. Cytogenetic analyses should be included in the clinical evaluation of patients with generalized epilepsy and complex phenotypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636323     DOI: 10.1111/j.0013-9580.2003.61702.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  15 in total

Review 1.  Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities?

Authors:  E Stephen; A D Kindley
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

2.  Implementation of chromosomal microarrays in a cohort of patients with intellectual disability at the Argentinean public health system.

Authors:  Lucía Daniela Espeche; Andrea Paula Solari; María Ángeles Mori; Rubén Martín Arenas; María Palomares; Myriam Pérez; Cinthia Martínez; Vanesa Lotersztein; Mabel Segovia; Romina Armando; Liliana Beatriz Dain; Julián Nevado; Pablo Lapunzina; Sandra Rozental
Journal:  Mol Biol Rep       Date:  2020-09-13       Impact factor: 2.316

3.  Identification and characterization of different SHOX gene deletions in patients with Leri-Weill dyschondrosteosys by MLPA assay.

Authors:  Valentina Gatta; Ivana Antonucci; Elisena Morizio; Chiara Palka; Rita Fischetto; Vahe Mokini; Stefano Tumini; Giuseppe Calabrese; Liborio Stuppia
Journal:  J Hum Genet       Date:  2006-11-08       Impact factor: 3.172

4.  Copy number variation plays an important role in clinical epilepsy.

Authors:  Heather Olson; Yiping Shen; Jennifer Avallone; Beth R Sheidley; Rebecca Pinsky; Ann M Bergin; Gerard T Berry; Frank H Duffy; Yaman Eksioglu; David J Harris; Fuki M Hisama; Eugenia Ho; Mira Irons; Christina M Jacobsen; Philip James; Sanjeev Kothare; Omar Khwaja; Jonathan Lipton; Tobias Loddenkemper; Jennifer Markowitz; Kiran Maski; J Thomas Megerian; Edward Neilan; Peter C Raffalli; Michael Robbins; Amy Roberts; Eugene Roe; Caitlin Rollins; Mustafa Sahin; Dean Sarco; Alison Schonwald; Sharon E Smith; Janet Soul; Joan M Stoler; Masanori Takeoka; Wen-Han Tan; Alcy R Torres; Peter Tsai; David K Urion; Laura Weissman; Robert Wolff; Bai-Lin Wu; David T Miller; Annapurna Poduri
Journal:  Ann Neurol       Date:  2014-06-13       Impact factor: 10.422

5.  SHOX haploinsufficiency presenting with isolated short long bones in the second and third trimester.

Authors:  Shwetha Ramachandrappa; Abhijit Kulkarni; Hina Gandhi; Cheryl Ellis; Renata Hutt; Lesley Roberts; Rosol Hamid; Aris Papageorghiou; Sahar Mansour
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

Review 6.  Genetic forms of epilepsies and other paroxysmal disorders.

Authors:  Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Semin Neurol       Date:  2014-09-05       Impact factor: 3.420

7.  Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice.

Authors:  Simon Trent; Tommaso Cassano; Gaurav Bedse; Obah A Ojarikre; Trevor Humby; William Davies
Journal:  Neuropsychopharmacology       Date:  2011-12-21       Impact factor: 7.853

8.  Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder.

Authors:  E Stergiakouli; K Langley; H Williams; J Walters; N M Williams; S Suren; I Giegling; L S Wilkinson; M J Owen; M C O'Donovan; D Rujescu; A Thapar; W Davies
Journal:  Genes Brain Behav       Date:  2011-01-24       Impact factor: 3.449

9.  Turner syndrome and sexual differentiation of the brain: implications for understanding male-biased neurodevelopmental disorders.

Authors:  Rebecca Christine Knickmeyer; Marsha Davenport
Journal:  J Neurodev Disord       Date:  2011-08-05       Impact factor: 4.025

10.  Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention.

Authors:  William Davies; Trevor Humby; Wendy Kong; Tamara Otter; Paul S Burgoyne; Lawrence S Wilkinson
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.